- Home
- ORKA vs AMAL Comparison
ORKA vs AMAL Comparison
Compare ORKA & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORKA | AMAL |
|---|---|---|
| Founded | 2004 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ORKA | AMAL |
|---|---|---|
| Price | $40.45 | $38.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $54.64 | $33.50 |
| AVG Volume (30 Days) | ★ 358.2K | 133.1K |
| Earning Date | 01-01-0001 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.41 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.18 |
| Revenue Next Year | N/A | $6.55 |
| P/E Ratio | ★ N/A | $11.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.49 | $25.13 |
| 52 Week High | $41.19 | $42.66 |
Technical Indicators
Market Signals| Indicator | ORKA | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 67.67 | 46.53 |
| Support Level | $26.02 | $36.59 |
| Resistance Level | N/A | $39.34 |
| Average True Range (ATR) | 2.58 | 1.28 |
| MACD | 0.55 | -0.25 |
| Stochastic Oscillator | 80.61 | 33.97 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.